Reducing Safety-Related Drug Attrition- An Interview with Gareth Waldron

Hosted By: Gerald Clarke
Rate this Podcast: 
Average: 3 (5 votes)
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

Safety-related drug attrition is obviously a huge problem in drug trials. How can companies work to reduce this? We spoke with Gareth Waldron Non-Clinical Safety Lead at Pfizer Neusentis about in vitro pharmacological profiling, how it could be implemented to reduce this attrition and the success stories so far.


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018